
Conference Coverage
about 1 month ago
AAO 2026: Setting realistic expectations with refractive IOLsabout 1 month ago
AAO 2026: Comprehensive ophthalmologists are the uveitis front lineabout 1 month ago
AAO 2026: The optic nerve is the barrier to sight in eye transplantabout 1 month ago
AAO 2026: Murtaza K. Adam, MD, on sutureless scleral-fixated IOLsTrending on the Eye Care Network
Q&A: What the FDA’s class-wide NAION warning on GLP-1s means for eye care
How Lambert-Eaton myasthenic syndrome presents around the eyes
Dazodalibep data put Sjögren screening in focus for ophthalmologists
The interplay between cardiac disease and the eye
Longer anti-VEGF intervals in AMD, BRVO, and DME: 3 clinical cases
Latest News

Dazodalibep data put Sjögren screening in focus for ophthalmologists

Q&A: What the FDA’s class-wide NAION warning on GLP-1s means for eye care

Geographic atrophy: Treatment decisions before foveal involvement

Tenpoint Therapeutics opens telehealth access to Yuvezzi for adults with presbyopia

Viridian's VRDN-008 sustains IgG suppression through 8 weeks in phase 1

Shorts










Digital Edition




Podcasts
Continuing Medical Education
All News

The agency concluded that GLP-1 receptor agonists carry a potential increased risk of the rare optic neuropathy and is adding it to the Warnings and Precautions section of every product's label.

Kiril Kiprovski, MD, of NYU Langone shares clinical clues and bedside tests for spotting Lambert-Eaton myasthenic syndrome.

MyoSpectrumNet pulls 3 public fundus datasets into 1 multi-output framework. Screening and grading accuracy held up against dedicated models, but the authors are open about where joint learning gave ground.

Few people starting tamoxifen require an ophthalmic evaluation during the following year.

Technician-led screening catches hidden ocular surface disease before cataract surgery and helps decide when to delay surgery.

October spotlights eye-care breakthroughs: phase 3 gene therapies, sustained delivery, and AAO trial data, plus 3 FDA clearances shaping retina, cataract, and TED care.

Now on the company's EYE7 smart glasses platform, Eva is designed to go beyond answering questions about the visual environment by reasoning about user needs and directly controlling the device's vision-enhancement features.

Christopher J. Rapuano, MD, discusses emergency eye care access, retina advances and responsible AI use in ophthalmology.

The FDA approved the Supplemental New Drug Application for phentolamine 0.75% (Ryzumvi, Opus Genetics/Viatris) to treat presbyopia.

Eye care providers urged FDA advisers to approve SYD-101, citing myopia’s lifelong risks, compounding gaps and STAR trial results.

Lambert-Eaton myasthenic syndrome is a rare autoimmune disorder of the neuromuscular junction that should be differentiated from myasthenia gravis, another neuromuscular junction disorder.

Luma, an eye-tracking and assessment tool, helps eye care professionals gain objective insights into visual performance.

Johnson & Johnson spotlights contrast-driven cataract outcomes at AAO 2026, touting TECNIS PureSee/Odyssey data, 1M implants, and SmartLOAD injector sustainability.

Arun C. Gulani, MD, applies his keratoconus classification to cross-linking, rings, transplant, lens surgery, and staged care.

Rheumatoid arthritis, is an autoimmune disorder, develops more often in women than men in a 3:1 ratio.
























